Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$127.41
-0.5%
$137.22
$123.00
$225.00
$3.78B1.25558,524 shs776,669 shs
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
$14.19
-2.2%
$14.89
$8.26
$19.41
$1.24B-0.011.31 million shs1.61 million shs
Envista Holdings Corporation stock logo
NVST
Envista
$19.70
-0.6%
$18.83
$14.22
$23.00
$3.36B12.47 million shs1.69 million shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$57.04
-1.7%
$58.54
$47.04
$103.81
$3.21B1.07850,408 shs935,162 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-0.32%-5.27%-1.75%-15.30%-12.66%
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
-2.21%+5.27%+0.71%+3.43%+10.60%
Envista Holdings Corporation stock logo
NVST
Envista
-0.51%-3.29%+3.76%+29.71%+16.88%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-1.67%-2.43%-5.56%+7.56%-18.23%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
4.8641 of 5 stars
4.42.00.04.82.92.51.9
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
3.2043 of 5 stars
4.50.00.00.01.84.20.6
Envista Holdings Corporation stock logo
NVST
Envista
3.3571 of 5 stars
2.21.00.03.83.40.01.9
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.4816 of 5 stars
3.41.00.00.02.43.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.73
Moderate Buy$210.2765.04% Upside
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
3.00
Buy$26.8989.49% Upside
Envista Holdings Corporation stock logo
NVST
Envista
2.33
Hold$20.232.69% Upside
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.78
Moderate Buy$84.1347.48% Upside

Current Analyst Ratings Breakdown

Latest LQDA, INSP, NVST, and PRCT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/15/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$200.00 ➝ $182.00
7/15/2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$71.00 ➝ $68.00
7/9/2025
Envista Holdings Corporation stock logo
NVST
Envista
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$19.00 ➝ $23.00
7/9/2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$70.00
7/7/2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform
6/12/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$23.00 ➝ $25.00
6/11/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$25.00 ➝ $23.00
6/2/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/28/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Outperform ➝ Sector Outperform$36.00 ➝ $37.00
5/28/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$20.00 ➝ $23.00
5/28/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$25.00
(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$802.80M4.68$1.70 per share74.92$23.01 per share5.54
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
$14M86.65N/AN/A$0.91 per share15.59
Envista Holdings Corporation stock logo
NVST
Envista
$2.51B1.33$1.65 per share11.93$17.05 per share1.16
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$224.50M14.06N/AN/A$7.71 per share7.40
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$53.51M$2.1758.7139.571.967.92%10.00%8.68%8/5/2025 (Estimated)
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
-$130.39M-$1.58N/AN/AN/A-903.80%-177.91%-60.15%8/6/2025 (Estimated)
Envista Holdings Corporation stock logo
NVST
Envista
-$1.12B-$6.53N/A16.281.25-44.90%4.07%2.25%8/6/2025 (Estimated)
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$91.41M-$1.70N/AN/AN/A-36.20%-28.09%-20.02%7/30/2025 (Estimated)

Latest LQDA, INSP, NVST, and PRCT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$0.41N/AN/AN/AN/AN/A
8/6/2025Q2 2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
-$0.43N/AN/AN/A$3.90 millionN/A
8/6/2025Q2 2025
Envista Holdings Corporation stock logo
NVST
Envista
$0.24N/AN/AN/A$638.21 millionN/A
8/5/2025Q2 2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$0.22N/AN/AN/A$214.50 millionN/A
5/8/2025Q1 2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
-$0.42-$0.45-$0.03-$0.45$3.23 million$3.12 million
5/5/2025Q1 2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-$0.23$0.10+$0.33$0.10$194.89 million$201.32 million
5/1/2025Q1 2025
Envista Holdings Corporation stock logo
NVST
Envista
$0.20$0.24+$0.04$0.10$608.17 million$616.90 million
4/24/2025Q1 2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$0.49-$0.45+$0.04-$0.45$65.39 million$69.16 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/AN/AN/AN/AN/A
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
N/AN/AN/AN/AN/A
Envista Holdings Corporation stock logo
NVST
Envista
N/AN/AN/AN/AN/A
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/A
9.01
7.44
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
2.08
2.93
2.91
Envista Holdings Corporation stock logo
NVST
Envista
0.43
2.12
1.82
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.13
8.95
7.75

Institutional Ownership

CompanyInstitutional Ownership
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
94.91%
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
64.54%
Envista Holdings Corporation stock logo
NVST
Envista
N/A
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
89.46%

Insider Ownership

CompanyInsider Ownership
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
4.10%
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
26.50%
Envista Holdings Corporation stock logo
NVST
Envista
1.30%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
6.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
1,24629.49 million28.29 millionOptionable
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
5085.49 million62.83 millionOptionable
Envista Holdings Corporation stock logo
NVST
Envista
12,300169.49 million167.28 millionOptionable
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
43055.33 million51.68 millionOptionable

Recent News About These Companies

PROCEPT BioRobotics (NASDAQ:PRCT) Now Covered by Stephens
PROCEPT BioRobotics Corporation (PRCT) - Yahoo Finance
PRCT PROCEPT BioRobotics Corporation - Seeking Alpha

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Inspire Medical Systems stock logo

Inspire Medical Systems NYSE:INSP

$127.41 -0.59 (-0.46%)
Closing price 07/16/2025 03:59 PM Eastern
Extended Trading
$127.46 +0.05 (+0.04%)
As of 07/16/2025 04:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Liquidia Technologies stock logo

Liquidia Technologies NASDAQ:LQDA

$14.19 -0.32 (-2.21%)
Closing price 07/16/2025 04:00 PM Eastern
Extended Trading
$14.38 +0.19 (+1.34%)
As of 07/16/2025 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Envista stock logo

Envista NYSE:NVST

$19.70 -0.11 (-0.56%)
Closing price 07/16/2025 03:59 PM Eastern
Extended Trading
$19.70 +0.00 (+0.03%)
As of 07/16/2025 05:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

PROCEPT BioRobotics stock logo

PROCEPT BioRobotics NASDAQ:PRCT

$57.04 -0.97 (-1.67%)
Closing price 07/16/2025 04:00 PM Eastern
Extended Trading
$55.87 -1.17 (-2.05%)
As of 07/16/2025 05:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.